CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented Growth
CBD Life Sciences (CBDL) announces the approval of its Mushroom Madness Rise Gummies for sale on Walmart Marketplace, a platform that experienced 60% year-over-year growth in gross merchandise volume. The product features a Lion's Mane mushroom blend targeting cognitive health benefits.
The company positions itself to capitalize on the growing functional mushroom market, projected to reach $42.4 billion by 2028. CBDL has recorded a 1405.46% revenue increase since February 2024 and expects further growth through this partnership. Walmart Marketplace, with over 100 million monthly visitors, generates more than 50% of Walmart's online sales through third-party sellers, contributing to e-commerce revenue exceeding $100 billion in 2024.
CBDL plans to expand its presence on Walmart Marketplace with additional products, including nano-CBD supplements and mushroom-enhanced nutritional powders.
CBD Life Sciences (CBDL) annuncia l'approvazione delle sue Caramelle Rise Mushroom Madness per la vendita su Walmart Marketplace, una piattaforma che ha registrato una crescita del 60% anno su anno nel volume della merce lordo. Il prodotto presenta un mix di funghi Lion's Mane mirato a benefici per la salute cognitiva.
L'azienda si posiziona per capitalizzare sul crescente mercato dei funghi funzionali, che si prevede raggiunga 42,4 miliardi di dollari entro il 2028. CBDL ha registrato un aumento del fatturato del 1405,46% da febbraio 2024 e si aspetta una crescita ulteriore grazie a questa collaborazione. Walmart Marketplace, con oltre 100 milioni di visitatori mensili, genera più del 50% delle vendite online di Walmart attraverso venditori terzi, contribuendo a un fatturato e-commerce che supera i 100 miliardi di dollari nel 2024.
CBDL prevede di ampliare la sua presenza su Walmart Marketplace con ulteriori prodotti, tra cui integratori nano-CBD e polveri nutritive arricchite con funghi.
CBD Life Sciences (CBDL) anuncia la aprobación de sus Gominolas Rise Mushroom Madness para la venta en Walmart Marketplace, una plataforma que experimentó un crecimiento del 60% interanual en el volumen bruto de mercancía. El producto presenta una mezcla de hongo Lion's Mane que apunta a beneficios para la salud cognitiva.
La compañía se posiciona para capitalizar el creciente mercado de los hongos funcionales, que se proyecta alcance 42.4 mil millones de dólares para 2028. CBDL ha registrado un aumento del 1405.46% en ingresos desde febrero de 2024 y espera un crecimiento adicional a través de esta asociación. Walmart Marketplace, con más de 100 millones de visitantes mensuales, genera más del 50% de las ventas en línea de Walmart a través de vendedores tercerizados, contribuyendo a unos ingresos de comercio electrónico que superan los 100 mil millones de dólares en 2024.
CBDL planea expandir su presencia en Walmart Marketplace con productos adicionales, incluyendo suplementos de nano-CBD y polvos nutricionales mejorados con hongos.
CBD 생명과학(CBDL)이 월마트 마켓플레이스에서 판매를 위한 '버섯 광란 라이즈 구미'의 승인을 발표했습니다. 이 플랫폼은 연간 60%의 성장률을 기록했습니다. 해당 제품은 인지 건강 혜택을 목표로 하는 사자의 갈기 버섯 혼합물을 특징으로 합니다.
회사는 2028년까지 424억 달러에 이를 것으로 예상되는 성장하는 기능성 버섯 시장을 활용할 수 있는 입지를 다지고 있습니다. CBDL은 2024년 2월 이후 1405.46%의 매출 증가를 기록했으며, 이번 파트너십을 통해 추가적인 성장을 기대하고 있습니다. 월마트 마켓플레이스는 매달 1억 명 이상의 방문자를 보유하고 있으며, 제3자 판매자를 통해 월마트 온라인 판매의 50% 이상을 차지하면서 2024년에는 1000억 달러를 초과하는 전자상거래 수익에 기여하고 있습니다.
CBDL은 나노-CBD 보충제와 버섯을 강화한 영양 가루 등을 포함한 추가 제품으로 월마트 마켓플레이스에서의 입지를 확대할 계획입니다.
CBD Life Sciences (CBDL) annonce l'approbation de ses Gummy Rise Mushroom Madness pour la vente sur Walmart Marketplace, une plateforme qui a connu une croissance de 60 % d'une année sur l'autre de son volume brut de marchandises. Le produit présente un mélange de champignon Lion's Mane visant à des bienfaits pour la santé cognitive.
L'entreprise se positionne pour capitaliser sur le marché croissant des champignons fonctionnels, prévu pour atteindre 42,4 milliards de dollars d'ici 2028. CBDL a enregistré une augmentation de 1405,46 % de ses revenus depuis février 2024 et s'attend à une croissance supplémentaire grâce à ce partenariat. Walmart Marketplace, avec plus de 100 millions de visiteurs mensuels, génère plus de 50 % des ventes en ligne de Walmart par le biais de vendeurs tiers, contribuant à des revenus de commerce électronique dépassant les 100 milliards de dollars en 2024.
CBDL prévoit d'élargir sa présence sur Walmart Marketplace avec des produits supplémentaires, y compris des compléments de nano-CBD et des poudres nutritionnelles enrichies en champignons.
CBD Life Sciences (CBDL) gibt die Genehmigung seines Mushroom Madness Rise Gummies zum Verkauf auf Walmart Marketplace bekannt, einer Plattform, die ein jährliches Wachstum von 60 % im Bruttowarenvolumen erlebt hat. Das Produkt enthält eine Mischung aus Löwenmähne-Pilzen, die auf kognitive Gesundheitsvorteile abzielt.
Das Unternehmen positioniert sich, um vom wachsenden Markt für funktionale Pilze zu profitieren, der voraussichtlich 42,4 Milliarden US-Dollar bis 2028 erreichen wird. CBDL hat seit Februar 2024 einen Umsatzanstieg von 1405,46 % verzeichnet und rechnet mit weiterem Wachstum durch diese Partnerschaft. Walmart Marketplace, mit über 100 Millionen monatlichen Besuchern, generiert mehr als 50 % des Online-Umsatzes von Walmart über Drittanbieter, was zu einem E-Commerce-Umsatz von über 100 Milliarden US-Dollar im Jahr 2024 beiträgt.
CBDL plant, seine Präsenz auf Walmart Marketplace mit zusätzlichen Produkten zu erweitern, darunter Nano-CBD-Ergänzungen und pilzverstärkte Nährstoffpulver.
- Secured approval for product listing on Walmart Marketplace, accessing over 100 million monthly visitors
- Recorded 1405.46% revenue increase since February 2024
- Entering functional mushroom market projected to reach $42.4 billion by 2028
- Plans to expand product line on Walmart Marketplace platform
- None.
Walmart Marketplace saw a
SCOTTSDALE, AZ / ACCESSWIRE / January 7, 2025 / CBD Life Sciences, Inc. (OTC PINK:CBDL), a leader in wellness innovation, is thrilled to announce that its Mushroom Madness Rise Gummies, featuring a powerful Lion's Mane mushroom blend, have officially been approved for sale and are now available on Walmart Marketplace. This monumental approval opens the door for CBDL to tap into Walmart's expansive e-commerce ecosystem, providing a pathway to substantial revenue growth while strengthening its position in the rapidly expanding functional mushroom market.
Expanding Market Potential
The global functional mushroom market continues to surge, projected to reach
Lisa Nelson, President and CEO of CBDL, commented on this milestone:
"This approval is more than just an entry into Walmart-it's a strategic step toward scaling our operations and driving significant shareholder value. We're not only gaining access to millions of health-conscious consumers but also leveraging Walmart's trusted platform to amplify our brand's reach and credibility."
The Walmart Marketplace Advantage
Walmart Marketplace, recognized as one of the fastest-growing online retail platforms, boasts over 100 million monthly visitors. With third-party sellers generating substantial portions of Walmart's e-commerce revenue, the platform offers unmatched scalability and visibility for emerging brands. CBDL's entry onto Walmart Marketplace provides logistical efficiencies, enhanced consumer trust, and a direct line to an enormous, ever-expanding customer base.
Industry reports indicate that third-party sellers often experience double-digit sales growth within months of launching on Walmart Marketplace. This offers CBDL an unprecedented opportunity to scale its revenues rapidly, further bolstered by Walmart's robust digital marketing support and fulfillment network.
Revenue Impact and Growth Strategy
CBD Life Sciences has already achieved impressive financial growth, recording a
The Mushroom Madness Rise Gummies are a strategic addition to CBDL's product lineup, aligning with the company's commitment to offering scientifically formulated, high-efficacy wellness products. These gummies not only serve a growing wellness market but also position CBDL to capture a significant share of the
As part of its long-term strategy, CBDL plans to launch additional top-selling products on Walmart Marketplace, including its highly anticipated nano-CBD supplements and mushroom-enhanced nutritional powders.
Commitment to Shareholders
CBDL remains steadfast in its mission to drive long-term shareholder value by continuously expanding into high-growth markets. The Walmart Marketplace approval is expected to further strengthen investor confidence, positioning the company as a market leader in innovative health solutions. With an expanding portfolio of products and a growing number of retail partnerships, CBDL is on track to deliver sustained financial growth and operational excellence.
Customers can purchase the product directly by visiting this link: https://www.walmart.com/ip/Rise-Mushrooms-Lion-s-Mane-Blend/14843512001?classType=REGULAR&from=/search
About CBD Life Sciences, Inc.
CBD Life Sciences, Inc. (OTC:CBDL) is a pioneering health and wellness company specializing in high-quality CBD products and functional supplements. With a focus on innovation, the company leverages advanced technology and scientific research to develop effective solutions that promote overall well-being. CBDL's diverse product range includes nano-enhanced CBD creamers, pain relief creams, and functional mushroom blends.
For more information about CBD Life Sciences, Inc. and its product offerings, visit www.thecbdvault.com
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
SOURCE: CBD Life Sciences Inc.
Related Images
View the original press release on accesswire.com
FAQ
What is the projected market size for functional mushrooms by 2028 according to CBDL's announcement?
What was CBDL's revenue growth percentage since February 2024?
What is Walmart Marketplace's contribution to Walmart's online sales?
What new products does CBDL plan to launch on Walmart Marketplace?